drugset / Trial / NCT00797797

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

NCT00797797

Phase 3 Completed 364 enrolled Forest Laboratories
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.

Timeline

Start
2008-11
Primary completion
2009-11
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 100 mg
Background Pregabalin Small molecule

Indications